Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs
about
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Antiviral activities of atractylon from Atractylodis RhizomaThe Influenza A Virus Genotype Determines the Antiviral Function of NF-κBPostviral Complications: Bacterial PneumoniaComparative transcriptome and potential antiviral signaling pathways analysis of the gills in the red swamp crayfish, Procambarus clarkii infected with White Spot Syndrome Virus (WSSV).Editorial: Influenza Virus Vaccines and Immunotherapies.Homeostatic Control of Innate Lung Inflammation by Vici Syndrome Gene Epg5 and Additional Autophagy Genes Promotes Influenza Pathogenesis.In-depth comparative transcriptome analysis of intestines of red swamp crayfish, Procambarus clarkii, infected with WSSV.Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production.Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro.Personalized medicine in severe influenza.The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.Protective effects of phillyrin against influenza A virus in vivo.Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice.Influenza A Virus PA Antagonizes Interferon-β by Interacting with Interferon Regulatory Factor 3.Pulmonary transcriptomic responses indicate a dual role of inflammation in pneumonia development and viral clearance during 2009 pandemic influenza infection.Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.Cytokine Profiles of Severe Influenza Virus-Related Complications in Children.The Role of Extracellular Histones in Influenza Virus Pathogenesis.Nlrp12 Mediates Adverse Neutrophil Recruitment during Influenza Virus Infection.Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection.Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury.Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes.The Future of Influenza Vaccines: A Historical and Clinical PerspectiveRe-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies
P2860
Q28076034-1FD4264E-B3CF-4433-AF06-E184EDEAA402Q28828421-6D822A9B-58BF-451C-994C-BB8A9882BC25Q28830060-CC7D4527-DAC3-40E1-8553-4D501902AC17Q29248089-0928A0D3-9687-4CE9-BE47-C7D53A47A42FQ33617091-3D7A3277-5105-4424-86EF-A7B7B643CBE4Q36310609-5780F636-D6C9-4AD4-B190-246D0C792F36Q36466493-717E272C-3665-4C2D-93A1-C18455F12D2EQ36990633-B700EB6F-1463-4CC9-B98E-DA4D4876C4B0Q38693815-FFA08505-925A-4EED-8BF5-46E75524E46FQ38721477-7E17C8F9-34EC-4607-9AC6-BB1667B74738Q38758702-2F203CB7-EEFD-4F8D-B0A1-179455D95BAEQ39223220-746E7EFE-974D-441A-84CE-01F61B203A95Q39669619-6858DF05-5DCE-465F-BD3F-FF2DBECE189EQ40471274-3ADC0D03-E4D3-4C76-8F47-963657C0F3F6Q41684158-E73F7FD7-F1C5-4D78-AF0D-1B45FBC5AF5BQ42377486-4AD20617-ADD5-4B65-85D8-51DC87DB42F5Q45323947-1A05B03D-ED26-4863-BB51-ED2BF61901C4Q45324457-E9504A4A-F658-4DE5-9227-80ACEA5EA621Q45325237-E38FD9A7-76D6-42DF-B16D-634827B6DE78Q47241356-803A913B-2D38-4CD0-8FF0-E68DE6657728Q47549703-AC2E4243-523D-4B53-B051-EB5EABB81761Q47554827-1DDC5249-1BD5-40BD-B8CD-8768ECC10863Q52667392-240E94C8-3837-4D54-8A14-6133F8C7E16FQ52717837-88CF6E1A-AF5E-44EE-BBB1-7AD099E23053Q55262373-AFFD3F3E-5E99-47B6-AB34-171814A55422Q57166818-8534B9FA-17FB-493C-BF98-7311809A15EDQ57930420-81FAB30D-A520-44A4-80AE-5A2085B5632A
P2860
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@ast
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@en
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@nl
type
label
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@ast
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@en
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@nl
prefLabel
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@ast
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@en
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@nl
P2860
P3181
P356
P1476
Modulating the Innate Immune R ...... Use of Anti-Inflammatory Drugs
@en
P2860
P3181
P356
10.3389/FIMMU.2015.00361
P407
P577
2015-01-01T00:00:00Z